Wolv:"Very positive message on the R&D section for all their drugs, and its not just spin."And you know that..... how?
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%